Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution
Go back to Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 18.06 +0.38 (2.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.68 | 52 Week High | $0.19 | |||
| Open | $17.90 | 52 Week Low | $0.07 | |||
| Day High | $18.32 | P/E | N/A | |||
| Day Low | $17.61 | EPS | $-0.01 | |||
| Volume | 2,607,678 | |||||
